Focus on Cancer Immunotherapy and Next-Generation Vaccines and a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. Eastern…
NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the…
Call Scheduled for Today, Thursday, March 31, 2022 at 5:00 pm ETHIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE NEWSWIRE) --…
ONS-5010 / LYTENAVA™ (bevacizumab-vikg), if approved, expected to receive 12 years of marketing exclusivityISELIN, N.J., March 31, 2022 (GLOBE NEWSWIRE)…
Clinicians reviewing ultrasound scan March 31, 2022 Industry leading vendor-neutral solution for automated 2D and 3D quantification for browser-accessible echocardiography…
– First description of new, comprehensive anellovirus antibody analysis tool, AnelloScan – – Cross-sectional study supports that anelloviruses are associated with…
Entered into an exclusive global license agreement with Organon to commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%) that includes a $10…
CD388 is a drug-Fc conjugate (DFC) from Cidara’s Cloudbreak® platform and is designed to transform the standard of care for…
NORCROSS, Ga., March 31, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target…
REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic…